MicuRx: Successfully Completes Phase III Clinical Trial of MRX-4 for Injection in China
- Written by PR Newswire
SHANGHAI, Nov. 29, 2024 /PRNewswire/ -- Recently, Shanghai MicuRx Pharmaceutical Co., Ltd. ("MicuRx", 688373.SH) announced the successful completion of its Phase III clinical trial of MRX-4 for injection transitioning to oral Contezolid tablets for the treatment of adult patients with complex skin and soft tissue infections (cSSTI) in China....
Read more: MicuRx: Successfully Completes Phase III Clinical Trial of MRX-4 for Injection in China














